BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Pharmacovigilance is ‘hotter’ than ever. A simple search on So
 cial Media can give a good idea of the impact of pandemic on Pharmacovigi
 lance. How the perceptions of clinical research\, drug approval and adver
 se events among the public have evolved\; adaptations to the regulatory f
 ramework to address challenges arising from the&nbsp\;current situation\;
  and the change to the way that ‘PV people’ work.\n\nAt the same time\, B
 rexit and implementation of the new regulatory base of pharmacovigilance 
 in the UK\, as well as in the Eurasian Economic Union (EAEU) countries\, 
 have transformed Pharmacovigilance to a key element brought to the attent
 ion of all pharmaceutical industry players. For years\, a globally harmon
 ized approach to Pharmacovigilance has been discussed as a concept for in
 tegrated regulations. Considering the recent developments\, are we Gettin
 g Closer or Further Away from Harmonized systems?\n\nThe third edition of
  the&nbsp\;International Pharmacovigilance Days\,&nbsp\;organized by LS A
 cademy\, will focus on all these topics\, among others:\n\n\nWhat are the
  points to be considered when a PV system is set up outside the EU?\nWhat
  are the inspection and quality aspects challenges under the new Legislat
 ion Era?\nIs a transition from an EU-QPPV Office to International QPPV Of
 fice required?\nHow has the COVID-19 affected the digital transformation 
 of PV? Is this ‘new way we work’ here to stay?\nPV Technologies reality c
 heck – where do we stand? Are the promises of technology coming true?\nAr
 e new PV business models required to meet current and future needs? Pharm
 acovigilance outsourcing and vendor oversight – what are the trends and b
 est practices?\nCurrent discussions for accelerated drug approval and saf
 ety monitoring: Will they have a further impact on patients’ involvement 
 on drug development?\n\nThe conference will be divided in 5 virtual appoi
 ntments from 14th to 18th June (afternoon CEST – 2\,5 hours each).\n\nThe
  Agenda will cover 3 main macro-areas:\n\n\nGlobalization of Pharmacovigi
 lance: Getting Closer or Further Away from Harmonized Systems?\nPharmacov
 igilance System: Best Practices and Case Studies\nPatient Involvement in 
 Drug Development and Vaccines\n\nCheck the website for the programme\n
DTEND:20210618T170000
DTSTAMP:20260512T225910Z
DTSTART:20210614T141500
LOCATION:\,
SEQUENCE:0
SUMMARY:Pharmacovigilance is ‘hotter’ than ever. A simple search on Social
  Media can give a good idea of the impact of pandemic on Pharmacovigilanc
 e. How t...
UID:2559c871-3f79-4a34-9cd9-049f91ad4960
END:VEVENT
END:VCALENDAR
